We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.025 | 1.56% | 1.625 | 1.60 | 1.65 | 1.675 | 1.60 | 1.60 | 11,401,604 | 10:40:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0447 | -0.36 | 1.87M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/1/2021 11:25 | Please don't buy in here bunz. You're a jinx. | hodhasharon | |
22/1/2021 11:22 | part of reason now considering buying here looking like growing demand for testing globally also thinking with US likely to increase testing | bunz3 | |
22/1/2021 10:56 | find this rise here interesting is some one building up a holding here while share price this low or is news expected will look back in later this afternoon ,or next week any helpful research would be appreciated | bunz3 | |
22/1/2021 10:42 | Do some research | jock3636 | |
22/1/2021 10:37 | researching here ,share price looks to have been dropping ,now looks like buyers loading up interested in hearing why buyers looking to be building up shares here again why this buying Today | bunz3 | |
22/1/2021 10:35 | About bloody time! | yasyas1 | |
22/1/2021 10:32 | looking like buying demand building up Today is news expected | bunz3 | |
22/1/2021 10:14 | can any one sell | bunz3 | |
22/1/2021 09:51 | Maybe the chap at BGF doesn't want to be the next idiot to slam the company by dumping just before the rerate? | loafofbread | |
21/1/2021 23:53 | Sorry to hear about ur mum dying, heard she went in a bad way | prof_pwhite | |
21/1/2021 23:52 | LOL what a tool | prof_pwhite | |
21/1/2021 21:48 | Just listened to USA news briefing ...Massive amount of money going in to testing facility's ......Dare i say it ..... GDR could multi bag from here !!!Never mind UK about to announce in near term | amaretto1 | |
21/1/2021 21:30 | Genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that it notified the Food and Drug Association (FDA) in the United States of its intention to import and distribute its Genedrive 96 SARS-CoV-2 Kit prior to an Emergency Use Authorization (EUA) determination, as described in the guidance on Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency, Section IV.C.2.16th Dec 2020 | blackvulture | |
21/1/2021 08:25 | But are GDR selling any tests kits in the USA? | pal44 | |
20/1/2021 23:50 | Covid live updates: New CDC chief calls for more testing; The U.S. is recording at least 199,700 new Covid-19 cases and at least 2,960 virus-related deaths each day,Biden's new CDC director calls to ramp up Covid testing, vaccinationsThe United States needs to quickly ramp up the amount and pace of Covid-19 testing and vaccinations to bring the current outbreak under control, Dr. Rochelle Walensky said in her first official statement as President Joe Biden's director of the Centers for Disease Control and Prevention."Better, healthier days lie ahead. But to get there, COVID-19 testing, surveillance, and vaccination must accelerate rapidly," Walensky said in a statement. "We must also confront the longstanding public health challenges of social and racial injustice and inequity that have demanded action for far too long."The country will also need to "make up for potentially lost ground in areas like suicide, substance use disorder and overdose, chronic diseases, and global health initiatives," she said.She added that officials will review all current guidance issued by the CDC under the Trump administration and will update it if needed "so that people can make decisions and take action based upon the best available evidence." She placed the CDC's principal deputy director Anne Schuchat in charge of the review process. | blackvulture | |
20/1/2021 23:25 | Will never happen. Hodhashron has confirmed its a fraud | professor_kemche | |
20/1/2021 22:49 | This is true, only if GDR gets its POCT to be approved by the FDA, or equivalent body in the EU. | divmad | |
20/1/2021 21:30 | Point-of-Care Tests Will Make a Breakthrough “COVID-19 has provided the impetus to develop new, low-cost molecular diagnostic platforms suitable for mass testing such as POCT. According to GlobalData’s pipeline products database, there are over 140 POCT in the pipeline, with over 25 products in approval processes and many likely to see approval in 2021. Companies such as Genedrive are in a great position to introduce large-scale molecular POCT to emerging markets through partnerships.” | mrshaungcm | |
20/1/2021 20:03 | There is no excuse for losses, unless you can't afford a ShareProphets subscription.Sign up and prosper! | professor_hodhasharon | |
20/1/2021 20:01 | big mistake, got 1200 in here! | latifs100 | |
20/1/2021 19:31 | i actually bought more today !! | amaretto1 | |
20/1/2021 19:27 | Hope so Hod | mrshaungcm |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions